Santa Cruz Biotechnology

CLCA1 (E-4) | Santa Cruz Biotechnology

mouse monoclonal IgG1; CLCA1 Antibody (E-4) is an IgG1 κ mouse monoclonal CLCA1 antibody (also designated CLCA1 antibody) that detects the CLCA1 protein of mouse, rat and human origin by WB, IP, IF and ELISA. CLCA1 Antibody (E-4) is available as both the non-conjugated anti-CLCA1 antibody form, as well as multiple conjugated forms of anti-CLCA1 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The calcium-activated chloride channel (CLCA) protein family, which includes the human homologs CLCA1 and CLCA2, display distinct tissue distribution patterns. CLCA1 is expressed as a precursor protein that is processed into two cell surface associated subunits and a group of proteins. CLCA1 is upregulated by interleukin-9 and regulates the expression of mucins. CLCA1 may provide a therapeutic target to control mucus overproduction in airway disease patients with cystic fibrosis. CLCA2 expression is downregulated in breast cancer and therefore, is thought to act as a tumor suppressor in normal cells. CLCA3 is a structurally divergent member of the CLCA family that does not function as a channel protein. CLCA4 is a CLCA member that is expressed in human rectal mucosa, CLCA5 shows strong expression in eye and spleen, and CLCA6 is primarily expressed in intestine and stomach.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.